Загрузка...
Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)
Platinum-based chemotherapy doublets have been the standard approach to first-line therapy for more than a decade. Many randomized trials testing new combinations have not been able to produce significant gains in patient outcomes when these studies have looked at an unselected patient population. T...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4104641/ https://ncbi.nlm.nih.gov/pubmed/25101242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00177 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|